• 1
    Mocarski, E. S. and Courcelle, C. T., Cytomegalovirus and their replication. In Fields, B., Knipe, D. M. and Howley, P. (Eds.) Virology. 4th ed. Raven Press, New York 2001, pp 26262673.
  • 2
    Riddell, S. R., Watanabe, K. S., Goodrich, J. M., Li, C. R., Agha, M. E. and Greenberg, P. D., Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science 1992. 257: 238241.
  • 3
    Weekes, M. P., Wills, M. R., Mynard, K., Carmichael, A. J. and Sissons, J. G., The memory cytotoxic T-lymphocyte (CTL) response to human cytomegalovirus infection contains individual peptide-specific CTL clones that have undergone extensive expansion in vivo. J. Virol. 1999. 73: 20992108.
  • 4
    Elkington, R., Walker, S., Crough, T., Menzies, M., Tellam, J., Bharadwaj, M. and Khanna, R., Ex vivo profiling of CD8+-T-cell responses to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriers. J. Virol. 2003. 77: 52265240.
  • 5
    Sacre, K., Carcelain, G., Cassoux, N., Fillet, A. M., Costagliola, D., Vittecoq, D., Salmon, D. et al., Repertoire, diversity, and differentiation of specific CD8 T cells are associated with immune protection against human cytomegalovirus disease. J. Exp. Med. 2005. 201: 19992010.
  • 6
    Diamond, D. J., York, J., Sun, J. Y., Wright, C. L. and Forman, S. J., Development of a candidate HLA-B A*0201 restricted peptide-based vaccine against human cytomegalovirus infection. Blood 1997. 90: 17511767.
  • 7
    Gratama, J. W., van Esser, J. W., Lamers, C. H., Tournay, C., Lowenberg, B., Bolhuis, R. L. and Cornelissen, J. J., Tetramer-based quantification of cytomegalovirus (CMV)-specific CD8+ T lymphocytes in T-cell-depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection. Blood 2001. 98: 13581364.
  • 8
    Masuoka, M., Yoshimuta, T., Hamada, M., Okamoto, M., Fumimori, T., Honda, J., Oizumi, K. and Itoh, K., Identification of the HLA-B-A24 peptide epitope within cytomegalovirus protein pp65 recognized by CMV-specific cytotoxic T lymphocytes. Viral Immunol. 2001. 14: 369377.
  • 9
    Yewdell, J. W. and Bennink, J. R., Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. Annu. Rev. Immunol. 1999. 17: 5188.
  • 10
    Parham, P. and Ohta, T., Population biology of antigen presentation by MHC class I molecules. Science 1996. 272: 6774.
  • 11
    Saper, M. A., Bjorkman, P. J. and Wiley, D. C., Refined structure of the human histocompatibility antigen HLA-B-A2 at 2.6 A resolution. J. Mol. Biol. 1991. 219: 277319.
  • 12
    Falk, K., Rotzschke, O., Grahovac, B., Schendel, D., Stevanovic, S., Jung, G. and Rammensee, H. G., Peptide motifs of HLA-B35 and -B37 molecules. Immunogenetics 1993. 38: 161162.
  • 13
    Schonbach, C., Miwa, K., Ibe, M., Shiga, H., Nokihara, K. and Takiguchi, M., Refined peptide HLA-B*3501 binding motif reveals differences in 9-mer to 11-mer peptide binding. Immunogenetics 1996. 45: 121129.
  • 14
    Hill, A. V., Elvin, J., Willis, A. C., Aidoo, M., Allsopp, C. E., Gotch, F. M., Gao, X. M. et al., Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature 1992. 360: 434439.
  • 15
    Germain, R. N. and Margulies, D. H., The biochemistry and cell biology of antigen processing and presentation. Annu. Rev. Immunol. 1993. 11: 403450.
  • 16
    Lawlor, D. A., Zemmour, J., Ennis, P. D. and Parham, P., Evolution of class-I MHC genes and proteins: from natural selection to thymic selection. Annu. Rev. Immunol. 1990. 8: 2363.
  • 17
    Gavin, M. A., Gilbert, M. J., Riddell, S. R., Greenberg, P. D. and Bevan, M. J., Alkali hydrolysis of recombinant proteins allows for the rapid identification of class I MHC-restricted CTL epitopes. J. Immunol. 1993. 151: 39713980.
  • 18
    Wills, M. R., Carmichael, A. J., Mynard, K., Jin, X., Weekes, M. P., Plachter, B. and Sissons, J. G., The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL. J. Virol. 1996. 70: 75697579.
  • 19
    Schonbach, C., Ibe, M., Shiga, H., Takamiya, Y., Miwa, K., Nokihara, K. and Takiguchi, M., Fine tuning of peptide binding to HLA-B*3501 molecules by nonanchor residues. J. Immunol. 1995. 154: 59515958.
  • 20
    Green, K. J., Miles, J. J., Tellam, J., van Zuylen, W. J., Connolly, G. and Burrows, S. R., Potent T cell response to a class I-binding 13-mer viral epitope and the influence of HLA-B micropolymorphism in controlling epitope length. Eur. J. Immunol. 2004. 34: 25102519.
  • 21
    Tynan, F. E., Borg, N. A., Miles, J. J., Beddoe, T., El-Hassen, D., Silins, S. L., van Zuylen, W. J. et al., High resolution structures of highly bulged viral epitopes bound to major histocompatibility complex class I. Implications for T-cell receptor engagement and T-cell immunodominance. J. Biol. Chem. 2005. 280: 2390023909.
  • 22
    Hogan, K. T., Clayberger, C., Bernhard, E. J., Walk, S. F., Ridge, J. P., Parham, P., Krensky, A. M. and Engelhard, V. H., Identification by site-directed mutagenesis of amino acid residues contributing to serologic and CTL-defined epitope differences between HLA-B-A2.1 and HLA-B-A2.3. J. Immunol. 1988. 141: 25192525.
  • 23
    Tussey, L. G., Matsui, M., Rowland-Jones, S., Warburton, R., Frelinger, J. A. and McMichael, A., Analysis of mutant HLA-B-A2 molecules. Differential effects on peptide binding and CTL recognition. J. Immunol. 1994. 152: 12131221.
  • 24
    Macdonald, W. A., Purcell, A. W., Mifsud, N. A., Ely, L. K., Williams, D. S., Chang, L., Gorman, J. J. et al., A naturally selected dimorphism within the HLA-B44 supertype alters class I structure, peptide repertoire, and T cell recognition. J. Exp. Med. 2003. 198: 679691.
  • 25
    Fleischhauer, K., Kernan, N. A., O'Reilly, R. J., Dupont, B. and Yang, S. Y., Bone marrow-allograft rejection by T lymphocytes recognizing a single amino acid difference in HLA-B44. N. Engl. J. Med. 1990. 323: 18181822.
  • 26
    Keever, C. A., Leong, N., Cunningham, I., Copelan, E. A., Avalos, B. R., Klein, J., Kapoor, N. et al., HLA-B44-directed cytotoxic T cells associated with acute graft-versus-host disease following unrelated bone marrow transplantation. Bone Marrow Transplant. 1994. 14: 137145.
  • 27
    Tynan, F. E., Elhassen, D., Purcell, A. W., Burrows, J. M., Borg, N. A., Miles, J. J., Williamson, N. A. et al., The immunogenicity of a viral cytotoxic T cell epitope is controlled by its MHC-bound conformation. J. Exp. Med. 2005. 202: 12491260.
  • 28
    Miles, J. J., Borg, N. A., Brennan, R. M., Tynan, F. E., Kjer-Nielsen, L., Silins, S. L., Bell, M. J. et al., TCRα genes direct MHC restriction in the potent human T cell response to a class-I-bound viral epitope. J. Immunol. 2006. 177: 68046814.
  • 29
    van der Burg, S. H., Visseren, M. J., Brandt, R. M., Kast, W. M. and Melief, C. J., Immunogenicity of peptides bound to MHC class I molecules depends on the MHC-peptide complex stability. J. Immunol. 1996. 156: 33083314.
  • 30
    Lewicki, H. A., Von Herrath, M. G., Evans, C. F., Whitton, J. L. and Oldstone, M. B., CTL escape viral variants. II. Biologic activity in vivo. Virology 1995. 211: 443450.
  • 31
    van der Most, R. G., Concepcion, R. J., Oseroff, C., Alexander, J., Southwood, S., Sidney, J., Chesnut, R. W. et al., Uncovering subdominant cytotoxic T-lymphocyte responses in lymphocytic choriomeningitis virus-infected BALB/c mice. J. Virol. 1997. 71: 51105114.
  • 32
    Burrows, S. R., Silins, S. L., Moss, D. J., Khanna, R., Misko, I. S. and Argaet, V. P., T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigen. J. Exp. Med. 1995. 182: 17031715.
  • 33
    Messaoudi, I., Guevara Patino, J. A., Dyall, R., LeMaoult, J. and Nikolich-Zugich, J., Direct link between mhc polymorphism, T cell avidity, and diversity in immune defense. Science 2002. 298: 17971800.
  • 34
    Nikolic-Zugic, J. and Bevan, M. J., Role of self-peptides in positively selecting the T-cell repertoire. Nature 1990. 344: 6567.
  • 35
    Rojo, S., Garcia, F., Villadangos, J. A. and Lopez de Castro, J. A., Changes in the repertoire of peptides bound to HLA-B27 subtypes and to site-specific mutants inside and outside pocket B. J. Exp. Med. 1993. 177: 613620.
  • 36
    Barouch, D., Friede, T., Stevanovic, S., Tussey, L., Smith, K., Rowland-Jones, S., Braud, V. et al., HLA-B-A2 subtypes are functionally distinct in peptide binding and presentation. J. Exp. Med. 1995. 182: 18471856.
  • 37
    Prilliman, K. R., Jackson, K. W., Lindsey, M., Wang, J., Crawford, D. and Hildebrand, W. H., HLA-B15 peptide ligands are preferentially anchored at their C termini. J. Immunol. 1999. 162: 72777284.
  • 38
    Garcia-Peydro, M., Marti, M. and Lopez de Castro, J. A., High T cell epitope sharing between two HLA-B27 subtypes (B*2705 and B*2709) differentially associated to ankylosing spondylitis. J. Immunol. 1999. 163: 22992305.
  • 39
    Barber, L. D., Percival, L., Arnett, K. L., Gumperz, J. E., Chen, L. and Parham, P., Polymorphism in the alpha 1 helix of the HLA-B heavy chain can have an overriding influence on peptide-binding specificity. J. Immunol. 1997. 158: 16601669.
  • 40
    Barber, L. D., Gillece-Castro, B., Percival, L., Li, X., Clayberger, C. and Parham, P., Overlap in the repertoires of peptides bound in vivo by a group of related class I HLA-B allotypes. Curr. Biol. 1995. 5: 179190.
  • 41
    Lopez, D., Rojo, S., Calvo, V. and Lopez de Castro, J. A., Peptide-presenting similarities among functionally distant HLA-B27 subtypes revealed by alloreactive T lymphocytes of unusual specificity. J. Immunol. 1992. 148: 9961002.
  • 42
    Salter, R. D. and Cresswell, P., Impaired assembly and transport of HLA-B-A and -B antigens in a mutant T×B cell hybrid. EMBO J. 1986. 5: 943949.
  • 43
    Khanna, R., Silins, S. L., Weng, Z., Gatchell, D., Burrows, S. R. and Cooper, L., Cytotoxic T cell recognition of allelic variants of HLA-B B35 bound to an Epstein-Barr virus epitope: influence of peptide conformation and TCR-peptide interaction. Eur. J. Immunol. 1999. 29: 15871597.
  • 44
    Blake, N., Lee, S., Redchenko, I., Thomas, W., Steven, N., Leese, A., Steigerwald-Mullen, P. et al., Human CD8+ T cell responses to EBV EBNA1: HLA-B class I presentation of the (Gly-Ala)-containing protein requires exogenous processing. Immunity 1997. 7: 791802.